Skip to content
The announcement of “maximum fair prices” for the first 10 medicines targeted under the Inflation Reduction Act (IRA) has renewed questions and concerns about […]
The economics of the Inflation Reduction Act’s impact on innovation Read More »
Drug price controls in the Inflation Reduction Act (IRA) involve unconstitutional coercion and will destroy innovation in transformational treatments that save patients’ lives, the
BIO files amicus brief challenging IRA drug price controls Read More »
Food and Drug Administration (FDA) approval of updated COVID-19 mRNA vaccines came earlier than expected this year, giving us a new weapon against the
FDA greenlights updated COVID vaccines in time for summer surge Read More »
Australia’s Wagner Sustainable Fuel wants to equip its sustainable aviation fuel (SAF) refinery with a joint solution from LanzaTech and LanzaJet that turns municipal
LanzaTech and LanzaJet joint technology eyed for Australian SAF plant Read More »
In recent years, the number of disruptive, cutting-edge therapies approved or under review by the Food and Drug Administration (FDA) has grown substantially. So-called
Innovative payment arrangements bring transformative therapies from the lab to patients Read More »
On Aug. 14, the World Health Organization (WHO) declared an international emergency as a highly virulent strain of mpox spreading from the Democratic Republic
WHO declares international health emergency over highly virulent mpox in Africa Read More »
Soania Mathur, a former family physician, who has had Parkinson’s disease for over 25 years, believes she knows what’s best for her. “As patients
FNIH’s new Parkinson’s program proves collaboration is key Read More »
While a new report shows childhood vaccination saved over a million lives and averted half a billion cases of disease during the past 30
Childhood vaccination saved more than 1 million lives CDC finds Read More »
The Food and Drug Administration (FDA) on Aug. 6 approved VORANIGO, the first targeted therapy for Grade 2 Isocitrate dehydrogenase (IDH) mutant glioma, a
FDA approves Servier’s VORANIGO for certain brain tumors Read More »
Amidst Typhoon Gaemi, the Biotechnology Innovation Organization (BIO) traveled to Taipei to co-host BIO Asia-Taiwan from July 26-30. Luckily, the weather was no match
BIO travels to Taipei to co-host BIO Asia-Taiwan Read More »
